| GSK621 |
6-氯-5-(2'-羟基-3'-甲氧基-[1,1'-联苯]-4-基)-3-(3-甲氧基苯基)-1H-吡咯并[3,2-D]嘧啶-2,4(3H,5H)-二酮 |
1346607-05-3 |
| CPI-169 |
化合物CPI169 |
1450655-76-1 |
| M2I-1 |
312271-03-7 |
312271-03-7 |
| 6-Chloro-1H-pyrazolo[3,4-b]pyrazine |
6-氯-1H-吡唑并[3,4-B]吡嗪 |
1260664-81-0 |
| TD 139 |
TD139 |
1450824-22-2 |
| MPI-0479605 |
N6-环己基-N2-(2-甲基-4-吗啉苯基)-9H-嘌呤-2,6-二胺 |
1246529-32-7 |
| CPI 360 |
1802175-06-9 |
1802175-06-9 |
| Mps1-IN-5 |
BAY1161909 |
1443763-60-7 |
| CD38 inhibitor 78c |
CD38 inhibitor |
1700637-55-3 |
| Azido-PEG7-acid |
叠氮-六聚乙二醇-羧酸 |
361189-66-4 |
| GSK 561679A |
3-(4-甲氧基-2-甲基苯基)-2,5-二甲基-N-[(1S)-1-(3-甲基-1,2,4-恶二唑-5-基)丙基]吡唑并[1,5-A]嘧啶-7-胺 |
885220-61-1 |
| BAY-1125976. |
CS-2913 |
1402608-02-9 |
| Brigatinib |
布格替尼 |
1197953-54-0 |
| Amino-PEG8-azide |
氨基-七聚乙二醇-叠氮 |
1333154-77-0 |
| AZD-5582 |
AZD 5582 |
1258392-53-8 |
| AD80 |
AD80 |
1384071-99-1 |
| ARV-766 |
ARV-766 |
2750830-09-0 |
| 1,3-Dioxolo[4,5-g]furo[3,4-b]quinolin-8(5H)-one, 9-(3-fluorophenyl)-6,9-dihydro-5-(2-hydroxyethyl)- |
化合物SU056 |
2376580-08-2 |
| 2-Butenamide, N-[4-[(3-chloro-2-fluorophenyl)amino]-7-[2-[(1R,5S)-3-methyl-3-azabicyclo[3.1.0]hex-1-yl]ethynyl]-6-quinazolinyl]-4-(4-morpholinyl)-, (2E)- |
EGFR-IN-76 |
2607829-38-7 |
| 2-Pyridinecarboxylic acid, 6-(4-ethoxyphenyl)-4-methoxy-, 1-methylethyl ester |
5MG |
2598242-66-9 |
QQ
微信
